Cargando…

Oxeiptosis core genes and their multi-omics analysis in hepatocellular carcinoma

Oxeiptosis is a recently discovered caspase-independent, non-inflammatory programmed cell death modality. Current studies suggest that oxeiptosis has crucial effects on biological processes in a variety of diseases. However, the mechanism of oxeiptosis in hepatocellular carcinoma (HCC) remains uncle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Sen, Li, Jinghao, Zhao, Ruiqi, Yu, Mengjiao, Peng, Lisheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637422/ https://www.ncbi.nlm.nih.gov/pubmed/37960791 http://dx.doi.org/10.1097/MD.0000000000036051

Ejemplares similares

Identification of potential core genes in esophageal carcinoma using bioinformatics analysis
por: Yang, Xiaojie, et al.
Publicado: (2021)

Identification of core genes and clinical outcomes in tumors originated from endoderm (gastric cancer and lung carcinoma) via bioinformatics analysis
por: Shi, Yewen, et al.
Publicado: (2021)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma
por: Wu, Zhulin, et al.
Publicado: (2020)

Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis
por: He, Bosheng, et al.
Publicado: (2017)

Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular carcinoma
por: Sun, Gaofeng, et al.
Publicado: (2017)

Change in the Treg/Th17 cell imbalance in hepatocellular carcinoma patients and its clinical value
por: Lan, Yong-Ting, et al.
Publicado: (2017)

Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early–intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial
por: Lee, Teng-Yu, et al.
Publicado: (2017)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

A comprehensive investigation on pan-cancer impacts of constitutive centromere associated network gene family by integrating multi-omics data: A CONSORT-compliant article
por: Su, Huimei, et al.
Publicado: (2022)

Common Variants of the Prostaglandin-Endoperoxide Synthase 2 Gene and Hepatocellular Carcinoma Susceptibility
por: Li, Hong-guang, et al.
Publicado: (2015)

Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023)

Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis
por: Peng, Jin-lin, et al.
Publicado: (2021)

Phenethyl isothiocyanate and dasatinib combination synergistically reduces hepatocellular carcinoma growth via cell cycle arrest and oxeiptosis
por: Strusi, Gabriele, et al.
Publicado: (2023)

Screening and identification of key genes between liver hepatocellular carcinoma (LIHC) and cholangiocarcinoma (CHOL) by bioinformatic analysis
por: Kang, Xindan, et al.
Publicado: (2020)

Integrated analysis of ceRNA network in hepatocellular carcinoma using bioinformatics analysis
por: Luo, Yu, et al.
Publicado: (2021)

Incidental detection of primary hepatocellular carcinoma on 18F-prostate-specific membrane antigen-1007 positron emission tomography/computed tomography imaging in a patient with prostate cancer: A case report
por: Zhao, Hongguang, et al.
Publicado: (2020)

Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma: A Consort Study
por: Ding, Xianglian, et al.
Publicado: (2016)

Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma
por: Qian, Hong, et al.
Publicado: (2021)

Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study
por: Wang, Lei, et al.
Publicado: (2023)

Clinical significance of down-regulated HINT2 in hepatocellular carcinoma
por: Zhou, Dong-Kai, et al.
Publicado: (2019)

Hepatocellular carcinoma treated with anti-epidermal growth factor receptor antibody nimotuzumab: A case report
por: Song, Peng, et al.
Publicado: (2017)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
por: Jiang, Bei-ge, et al.
Publicado: (2015)

Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib: A retrospective analysis
por: Dong, Dong, et al.
Publicado: (2022)

Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma
por: Xie, Haixiang, et al.
Publicado: (2023)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review
por: Bu, Fan, et al.
Publicado: (2022)

Efficacy and safety of transarterial chemoembolization plus lenvatinib in the treatment of advanced hepatocellular carcinoma: A meta-analysis
por: Li, Dailong, et al.
Publicado: (2023)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

Ectopic hepatocellular carcinoma manifesting multiple abdominal masses: A case report
por: Jin, RenAn, et al.
Publicado: (2017)

Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk
por: Li, Hong-Guang, et al.
Publicado: (2015)

Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma
por: Yan, Xinjian, et al.
Publicado: (2020)

Efficacy of treatment regimens for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Anaplastic thyroid carcinoma combined with sclerosing mucoepidermoid carcinoma with eosinophilia: A case report
por: Mao, Ruiqi, et al.
Publicado: (2020)

Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis
por: Liu, Hong, et al.
Publicado: (2018)

Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2016)

Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

The role of definitive local treatment in metastatic hepatocellular carcinoma patients: A SEER-based study
por: Su, Mingxue, et al.
Publicado: (2018)

Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma
por: Yu, Youlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e5m73klguc68ddt0vai3gk0f8n